- Home
- / Bliss Gvs Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Bliss Gvs Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
₹8 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.6B | 8.9B | 6.8B | 5.7B | 7.4B | 7.5B | 7.7B | 8.0B |
| Cost of goods sold | 1.9B | 6.1B | 4.4B | 3.3B | 3.9B | 4.0B | 3.8B | 4.1B |
| Gross profit | 1.8B | 2.9B | 2.5B | 2.5B | 3.6B | 3.5B | 3.9B | 4.0B |
| Gross profit margin, % | 48.9% | 32.3% | 36.6% | 43.7% | 48.3% | 46.9% | 50.7% | 49.4% |
| Operating expense total | 815.9M | 1.3B | 1.3B | 1.4B | 2.4B | 2.3B | 2.4B | 2.6B |
| Depreciation and amortization | 90.7M | 89.4M | 125.9M | 172.3M | 173.3M | 186.7M | 263.8M | 294.2M |
| EBITDA | 962.0M | 1.6B | 1.2B | 1.1B | 1.2B | 1.2B | 1.5B | 1.4B |
| EBITDA margin, % | 26.4% | 18.1% | 18.1% | 18.8% | 16.0% | 15.7% | 19.7% | 17.3% |
| EBIT | 618.2M | 1.5B | 987.5M | 922.1M | 298.2M | 1.0B | 1.0B | 1.1B |
| EBIT margin, % | 17.0% | 17.1% | 14.5% | 16.2% | 4.0% | 13.5% | 13.1% | 14.3% |
| Interest income | 46.8M | 68.1M | 66.8M | 95.8M | 88.2M | 75.0M | 117.9M | 151.5M |
| Interest expense | 86.0M | 44.1M | 54.1M | 55.1M | 47.4M | 37.4M | 64.2M | 81.2M |
| Pre tax profit | 639.9M | 1.8B | 1.3B | 1.0B | 541.7M | 1.1B | 1.2B | 1.3B |
| Income tax expense | 322.7M | 552.5M | 337.1M | 301.6M | 310.4M | 293.4M | 352.9M | 353.8M |
| Net Income | 317.2M | 1.3B | 952.5M | 739.7M | 231.3M | 767.3M | 815.8M | 902.6M |